ORLAAM
LEVOMETHADYL ACETATE HYDROCHLORIDE
Approval overview ORLAAM is listed in Drugs@FDA under application 020315 (NDA).
Review priority: STANDARD Marketing status: Discontinued Active ingredient LEVOMETHADYL ACETATE HYDROCHLORIDE Form and strength CONCENTRATE;ORAL - 10MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** Sponsor ROXANE Submission history Latest submission status date: 2007-12-07 00:00:00.
Structured Monograph
Clinical summary
Approval overview ORLAAM is listed in Drugs@FDA under application 020315 (NDA). Review priority: STANDARD Marketing status: Discontinued Active ingredient LEVOMETHADYL ACETATE HYDROCHLORIDE Form and strength CONCENTRATE;ORAL - 10MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** Sponsor ROXANE Submission history Latest submission status date: 2007-12-07 00:00:00. Submission type: SUPPL.
Monitoring
- • Marketing status: Discontinued
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.